Schedule 13G ownership disclosure
TRANSLATE BIO INC
Security class unavailable · CUSIP: 89374L104
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-21-000004
- Form type
- SC 13G
- Filer
- TAKEDA PHARMACEUTICAL CO LTD
- CIK
- CIK 1395064
- Filed
- Jan 25, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership